102 related articles for article (PubMed ID: 6137226)
1. Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
Dawson JR; Canepa-Anson R; Kuan P; Reuben SR; Poole-Wilson PA; Sutton GC
Br Heart J; 1983 Sep; 50(3):282-9. PubMed ID: 6137226
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
Dawson JR; Canepa-Anson R; Kuan P; Whitaker NH; Carnie J; Warnes C; Reuben SR; Poole-Wilson PA; Sutton GC
Br Med J (Clin Res Ed); 1981 May; 282(6274):1423-6. PubMed ID: 6112039
[TBL] [Abstract][Full Text] [Related]
3. Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.
Bayliss J; Norell M; Canepa-Anson R; Reuben SR; Poole-Wilson PA; Sutton GC
Br Heart J; 1983 Mar; 49(3):214-21. PubMed ID: 6830658
[TBL] [Abstract][Full Text] [Related]
4. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
[TBL] [Abstract][Full Text] [Related]
5. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
Uretsky BF; Seecof RM; Reddy PS
Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
[TBL] [Abstract][Full Text] [Related]
6. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
Weber RW; Nelson HS
Pharmacotherapy; 1984; 4(1):1-10. PubMed ID: 6142449
[TBL] [Abstract][Full Text] [Related]
7. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.
Weber KT; Andrews V; Janicki JS; Likoff M; Reichek N
Circulation; 1982 Dec; 66(6):1262-7. PubMed ID: 6128086
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
[TBL] [Abstract][Full Text] [Related]
9. Management of severe chronic CHF with oral pirbuterol.
Awan NA; Needham K; Evenson MK; Mason DT
Acta Med Scand Suppl; 1981; 652():155-62. PubMed ID: 6949462
[No Abstract] [Full Text] [Related]
10. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
Petein M; Levine TB; Cohn JN
Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
[TBL] [Abstract][Full Text] [Related]
11. Potential value of oral beta 2-adrenoceptor agonists in congestive heart failure: a haemodynamic and metabolic study.
Timmis AD; Bergman G; Walker L; Monaghan MJ; Jewitt DE
Int J Cardiol; 1984 Mar; 5(3):327-38. PubMed ID: 6706438
[TBL] [Abstract][Full Text] [Related]
12. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
Biernacki W; Prince K; Whyte K; MacNee W; Flenley DC
Am Rev Respir Dis; 1989 Feb; 139(2):492-7. PubMed ID: 2563321
[TBL] [Abstract][Full Text] [Related]
13. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.
MacNee W; Wathen CG; Hannan WJ; Flenley DC; Muir AL
Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1169-72. PubMed ID: 6138118
[TBL] [Abstract][Full Text] [Related]
14. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.
Kukin ML; Kalman J; Mannino MM; Buchholz-Varley C; Ocampo O
Heart; 1997 Nov; 78(5):444-9. PubMed ID: 9415001
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
Awan NA; Needham K; Evenson MK; Hermanovich J; Joye JA; DeMaria AN; Mason DT
Am Heart J; 1981 Sep; 102(3 Pt 2):555-63. PubMed ID: 7270402
[No Abstract] [Full Text] [Related]
16. Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure.
Canepa-Anson R; Dawson JR; Kuan P; Warnes CA; Poole-Wilson PA; Reuben SR; Sutton GC
Am Heart J; 1981 Sep; 102(3 Pt 2):578-83. PubMed ID: 6115575
[No Abstract] [Full Text] [Related]
17. Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.
Canepa-Anson R; Dawson JR; Kuan P; Poole-Wilson PA; Sutton GC; Cockrill B; Reuben SR
Br J Clin Pharmacol; 1987 Feb; 23(2):173-81. PubMed ID: 3828194
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure.
Colucci WS; Alexander RW; Mudge GH; Rude RE; Holman BL; Wynne J; Grossman W; Braunwald E
Am Heart J; 1981 Sep; 102(3 Pt 2):564-8. PubMed ID: 6115573
[No Abstract] [Full Text] [Related]
19. Response of pulmonary circulation to oral pirbuterol in chronic airflow obstruction.
Peacock A; Busst C; Dawkins K; Denison DM
Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1178-80. PubMed ID: 6138119
[TBL] [Abstract][Full Text] [Related]
20. [Drug therapy of heart failure].
Follath F
Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
